Jaime LaMontagne named chief marketing officer of Astrin Biosciences

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Jaime LaMontagne

Jaime LaMontagne was appointed chief marketing officer of Astrin Biosciences. 

LaMontagne was most recently chief marketing officer of Exact Sciences. Prior to Exact Sciences, LaMontagne held senior leadership roles at Medtronic and Smiths Medical (now ICU Medical). 

LaMontagne’s appointment comes as Astrin expands its clinical program for its early cancer detection test for women with dense breasts, which makes up almost half of the female population. Early detection for this patient population is one of the most difficult and expensive cancers to screen. Astrin is planning to launch its first test this fall.

Table of Contents

YOU MAY BE INTERESTED IN

Mina Sedrak, director of the UCLA Center for Cancer and Aging and director of Cancer Control and Survivorship Research at the UCLA Health Jonsson Comprehensive Cancer Center, and Vijaya Raj Bhatt professor and medical director of the Leukemia Program at the University of Nebraska Medical Center, were selected to serve as co-chairs of the Cancer in the Older Adult Committee for The Alliance for Clinical Trials in Oncology.
Further positive results from the phase III SERENA-6 trial showed camizestrant plus a cyclin-dependent kinase 4/6 inhibitor—palbociclib, ribociclib or abemaciclib—maintained its progression-free survival benefit with longer follow-up and delivered a statistically significant and clinically meaningful improvement in second progression-free survival, demonstrating sustained benefit beyond initial treatment. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login